Skip to main content
Advertising

Originally published Friday, November 16, 2012 at 5:37 PM

  • Share:
           
  • Comments (0)
  • Print

Ameridose in Mass. to remain closed through year

A Massachusetts drug company with the same founders as a compounding pharmacy tied to a deadly meningitis outbreak has agreed with state regulators to remain closed through the year.

The Associated Press

Most Popular Comments
Hide / Show comments
No comments have been posted to this article.
Start the conversation >

advertising

BOSTON —

A Massachusetts drug company with the same founders as a compounding pharmacy tied to a deadly meningitis outbreak has agreed with state regulators to remain closed through the year.

Ameridose first agreed to close for inspection in October after tainted steroids from its sister company, the New England Compounding Center, were linked to a fungal meningitis outbreak that caused 32 deaths. The agreement has been extended several times. The latest would have expired Monday.

Ameridose has laid off most workers and recalled its products, though none has been found contaminated. The company makes injectable drugs for hospitals.

The U.S. Food and Drug Administration said Monday that its monthlong inspection of Ameridose found potential sources of contamination, including leaky ceilings and insects. Ameridose has said it'll work to address those issues.

News where, when and how you want it

Email Icon

Career Center Blog

Career Center Blog

Bad email habits to break today


Advertising